MedPath
NMPA Approval

Neratinib Maleate Tablets

国药准字H20249180

October 22, 2024

Drug Information

马来酸奈拉替尼片

片剂

40mg(按C₃₀H₂₉ClN₆O₃计)

化学药品

October 22, 2024

Company Information

Applicant Company

南京江宁科学园科建路699号

Manufacturing Company

南京江宁科学园科建路699号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

马来酸奈拉替尼片 - NMPA 批准文号 | MedPath